NO307031B1 - Farmasøytiske produkter for legning av tumorsykdommer, og fremgangsmåte for fremstilling av disse - Google Patents

Farmasøytiske produkter for legning av tumorsykdommer, og fremgangsmåte for fremstilling av disse

Info

Publication number
NO307031B1
NO307031B1 NO941590A NO941590A NO307031B1 NO 307031 B1 NO307031 B1 NO 307031B1 NO 941590 A NO941590 A NO 941590A NO 941590 A NO941590 A NO 941590A NO 307031 B1 NO307031 B1 NO 307031B1
Authority
NO
Norway
Prior art keywords
healing
preparation
methods
pharmaceutical products
tumor diseases
Prior art date
Application number
NO941590A
Other languages
English (en)
Other versions
NO941590L (no
NO941590D0 (no
Inventor
Gsbor Somlyai
Original Assignee
Hyd Kutato Fejleszto Kft
Gsbor Somlyai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyd Kutato Fejleszto Kft, Gsbor Somlyai filed Critical Hyd Kutato Fejleszto Kft
Publication of NO941590D0 publication Critical patent/NO941590D0/no
Publication of NO941590L publication Critical patent/NO941590L/no
Publication of NO307031B1 publication Critical patent/NO307031B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO941590A 1991-10-31 1994-04-29 Farmasøytiske produkter for legning av tumorsykdommer, og fremgangsmåte for fremstilling av disse NO307031B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases
PCT/HU1992/000036 WO1993008794A1 (en) 1991-10-31 1992-09-28 Pharmaceutical products for curing tumorous diseases and process for preparing same

Publications (3)

Publication Number Publication Date
NO941590D0 NO941590D0 (no) 1994-04-29
NO941590L NO941590L (no) 1994-06-23
NO307031B1 true NO307031B1 (no) 2000-01-31

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941590A NO307031B1 (no) 1991-10-31 1994-04-29 Farmasøytiske produkter for legning av tumorsykdommer, og fremgangsmåte for fremstilling av disse

Country Status (22)

Country Link
US (1) US5855921A (no)
JP (1) JP3569916B2 (no)
KR (1) KR100253874B1 (no)
CN (1) CN1045162C (no)
AT (1) AT402692B (no)
BE (1) BE1006186A3 (no)
CA (1) CA2122612C (no)
CH (1) CH685282A5 (no)
CZ (1) CZ282379B6 (no)
DE (1) DE4232465B4 (no)
DK (1) DK170832B1 (no)
ES (1) ES2077530B1 (no)
FI (1) FI114010B (no)
FR (1) FR2683148B1 (no)
GB (1) GB2276086B (no)
HU (1) HU208084B (no)
IT (1) IT1255390B (no)
LU (1) LU88175A1 (no)
NL (1) NL194664C (no)
NO (1) NO307031B1 (no)
SE (1) SE513624C2 (no)
WO (1) WO1993008794A1 (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69428213T2 (de) * 1994-01-06 2002-06-13 Hyd Kutato-Fejleszto Ktf, Budapest Nahrungsmittel zur verhinderung der entwicklung von erkrankungen und verfahren zur herstellung dieser nahrungsmittel
HU214824B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Bőrbetegségek kezelésére és megelőzésére alkalmas kozmetikai, higiéniai, valamint szépség- és testápolási készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
WO2003068919A2 (en) * 2002-02-12 2003-08-21 The Regents Of The University Of California Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
CA2494715C (en) 2002-07-30 2014-07-08 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates using mass spectrometry
AU2002321678A1 (en) * 2002-09-09 2004-03-29 Boros Béla Oxygen-enriched water, treated within a magnetic field and heavy water
SG149699A1 (en) * 2002-09-13 2009-02-27 Univ California Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
JP4611025B2 (ja) 2002-11-04 2011-01-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 体内のブドウ糖または脂肪酸の代謝に関する高処理量測定のための重水素化ブドウ糖または脂肪の耐性試験
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水(スーパーライトウォーター)を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) * 2004-06-03 2005-12-15 Kunihiro Seki 低重水素濃度食品の生産装置
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
JP2008529491A (ja) * 2005-02-08 2008-08-07 ウッドフォード アソシエーツ リミテッド 1h216oが濃縮されたアルコール飲料
US20080138470A1 (en) * 2005-02-08 2008-06-12 Sergey Pavlovich Soloviev Non-Alcoholic Beverage Enriched With 1H216O
KR100928384B1 (ko) * 2005-03-05 2009-11-23 세르게이 파브로비치 솔로비에프 1h216o가 강화된 화장품 조성물
US20080118463A1 (en) * 2005-03-11 2008-05-22 Igor Anatolievich Pomytkin Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof
US20080160102A1 (en) * 2005-03-11 2008-07-03 Igor Anatolievich Pomytkin Compositions For Disfecing Inanimate Surfaces
US20080103092A1 (en) * 2005-03-11 2008-05-01 Pomytkin Igor A Methods for Intradermal, Transdermal or Transmucosal Delivery of Biologically Active Substances
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
US20080292718A1 (en) * 2005-12-12 2008-11-27 Igor Anatolievich Pomytkin Method for Suppression Appetite and Food Intake
WO2007069933A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method for decreasing postprandial glucose excursion
WO2007069934A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method of treating metabolic syndrome
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE202009018629U1 (de) 2009-04-21 2012-06-11 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
CN103562199B (zh) * 2011-05-27 2016-03-30 百时美施贵宝公司 作为丙型肝炎病毒抑制剂的掺入氘的三肽
HUP1100290A2 (en) * 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
JP2014526685A (ja) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 代謝流量測定、画像化、および顕微鏡法
CA2858368A1 (en) 2011-12-07 2013-06-13 Glaxosmithkline Llc Methods for determining total body skeletal muscle mass
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
WO2014088441A1 (en) * 2012-12-03 2014-06-12 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
JP2017526638A (ja) * 2014-06-30 2017-09-14 ミトコンドリアル サブストレート インベンション リミテッドMitochondrial Substrate Invention Limited 認知機能向上のための栄養素溶液
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
WO2018053578A1 (en) * 2016-09-21 2018-03-29 Ambrosios Kambouris Isotopic compositions
MX2020006939A (es) 2018-01-02 2020-11-24 Botanical Water Tech Ip Ltd Composiciones isotopicas ii.
WO2019174659A1 (de) 2018-03-15 2019-09-19 Karl Bau Gmbh Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
AU1966188A (en) * 1987-08-07 1989-03-09 Mallinckrodt, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
SE9401406L (sv) 1994-06-07
NO941590L (no) 1994-06-23
SE513624C2 (sv) 2000-10-09
ES2077530A1 (es) 1995-11-16
HU208084B (en) 1993-08-30
US5855921A (en) 1999-01-05
CN1045162C (zh) 1999-09-22
JP3569916B2 (ja) 2004-09-29
SE9401406D0 (sv) 1994-04-25
NL9220026A (nl) 1994-09-01
HU913437D0 (en) 1992-01-28
CN1071836A (zh) 1993-05-12
AT402692B (de) 1997-07-25
ATA902992A (de) 1996-12-15
WO1993008794A1 (en) 1993-05-13
CA2122612A1 (en) 1993-05-13
FR2683148A1 (fr) 1993-05-07
FI941979A (fi) 1994-06-29
NO941590D0 (no) 1994-04-29
ITMI922233A0 (it) 1992-09-28
LU88175A1 (fr) 1993-03-15
FR2683148B1 (fr) 1994-09-09
CA2122612C (en) 2003-02-04
DE4232465A1 (de) 1993-05-06
FI941979A0 (fi) 1994-04-29
ITMI922233A1 (it) 1994-03-28
KR100253874B1 (ko) 2000-04-15
GB2276086A (en) 1994-09-21
FI114010B (fi) 2004-07-30
ES2077530B1 (es) 1996-07-01
DK170832B1 (da) 1996-02-05
NL194664B (nl) 2002-07-01
GB9408654D0 (en) 1994-07-20
KR930007461A (ko) 1993-05-20
NL194664C (nl) 2002-11-04
CZ282379B6 (cs) 1997-07-16
GB2276086B (en) 1995-09-27
IT1255390B (it) 1995-10-31
CH685282A5 (de) 1995-05-31
CZ102094A3 (en) 1994-12-15
JPH08501275A (ja) 1996-02-13
BE1006186A3 (fr) 1994-06-07
DE4232465B4 (de) 2008-11-06

Similar Documents

Publication Publication Date Title
NO307031B1 (no) Farmasøytiske produkter for legning av tumorsykdommer, og fremgangsmåte for fremstilling av disse
NO893896L (no) Farmasoeytiske formuleringer og fremgangsmaate for fremstilling av disse.
FI925737A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara indol-3-ylalkylpiperazinderivat
NO894296L (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
PT86870A (pt) Pharmaceutical tablet pharmaceutical granulate and process for their preparation
NO974874D0 (no) Systemer og fremgangsmåter for direktestyrt ferdigfremstilling av blodprodukter som blodplater innhöstet for terapautiske formål
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
NO893240L (no) Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer.
FI880195A (fi) Terapeutiska produkter.
NO933000D0 (no) Anvendelse av c1-inaktivator for fremstilling av et legemiddel for profylakse og behandling av bestemte sykdommer
DK287188D0 (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK420188D0 (da) Spiseligt produkt og fremgangsmaade til fremstilling deraf
IT8947616A0 (it) Preparato per il trattamento e la cura delle emorroidi
NO901396L (no) Fytosanitaere preparater, deres fremstilling og deres anvendelse for behandling av kryptogame sykdommer.
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
DK424987A (da) Farmaceutisk praeparat til indgivelse gennem huden og fremgangsmaade til dets fremstilling
FI960740A0 (fi) Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi, niiden käyttö farmaseuttisten valmisteiden valmistukseen ja niitä sisältäviä lääkkeitä
DK13989A (da) Anvendelse af tnf og lt til fremstilling af laegemidler.
NO893291D0 (no) Fremgangsmaate for fremstilling av nye benzasolderivater og farmasoeytiske preparater derav.
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
DE68926469D1 (de) Alkaloid-Verbindungen, pharmazeutische Zubereitungen und Verwendungsmethode
DK241189D0 (da) Kosmetisk produkt og fremgangsmaade til fremstilling deraf
NO941426D0 (no) Antisporiatiske farmasöytiske preparater og fremgangsmåte for fremstilling av slike

Legal Events

Date Code Title Description
MK1K Patent expired